TruBridge Croissance future
Future contrôle des critères 3/6
TruBridge devrait augmenter ses bénéfices et son chiffre d'affaires de 25% et de 4.8% par an respectivement. Le BPA devrait croître de de 32.7% par an. Le rendement des capitaux propres devrait être 5.3% dans 3 ans.
Informations clés
25.0%
Taux de croissance des bénéfices
32.73%
Taux de croissance du BPA
| Healthcare Services croissance des bénéfices | 22.3% |
| Taux de croissance des recettes | 4.8% |
| Rendement futur des capitaux propres | 5.31% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 15 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour du récit • Apr 17
TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.
Nouveau récit • Apr 16
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Apr 14
TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking AlphaMise à jour du récit • Apr 02
TBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.
Nouveau récit • Apr 02
AI Expansion And Global Delivery Shift Will Shape A Steady But Capped Future
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and electronic health record solutions to hospitals and healthcare providers, with a particular focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Article d’analyse • Feb 12
Returns At TruBridge (NASDAQ:TBRG) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Mise à jour du récit • Jan 28
TBRG: Revenue Cycle Focus And EHR Stability Will Test Execution Outcomes
Narrative Update The analyst price target for TruBridge has shifted modestly higher to about $22.67 per share, supported by analysts citing the potential of its Revenue Cycle Management focus alongside a steadier Electronic Health Records business, while still calling out execution risk after recent periods of low growth. Analyst Commentary Recent research points to a mixed but constructive view on TruBridge, with analysts focusing on the shift toward Revenue Cycle Management and the steadier Electronic Health Records business when considering valuation and execution risk.Mise à jour du récit • Jan 12
TBRG: Revenue Cycle Realignment And EHR Stability Will Require Steady Execution
Narrative Update The analyst price target for TruBridge now centers around US$23, a modest lift from the prior US$22.60. Analysts point to the potential of the Revenue Cycle Management opportunity alongside a steadier Electronic Health Records business, while still flagging execution risk after recent periods of low growth.Mise à jour du récit • Dec 17
TBRG: Revenue Cycle Shift Will Demand Proven Execution Before Rerating
Analysts raised their price target on TruBridge modestly, citing improving growth prospects from the company’s shift toward revenue cycle management as evidence builds of its long-term earnings potential. Analyst Commentary Bullish Takeaways Bullish analysts view the company’s realignment toward revenue cycle management as a structurally higher growth opportunity compared with its legacy clinical software offerings.Mise à jour du récit • Dec 03
TBRG: Revenue Cycle Pivot Will Require Clear Execution Evidence In 2025
Analysts have nudged their price target on TruBridge slightly higher to approximately $22.60 per share. This reflects increased confidence that the company’s shift toward revenue cycle management can unlock more attractive, evidence-based growth than its legacy clinical software focus.Mise à jour du récit • Nov 19
TBRG: Measured Optimism Will Depend On Evidence Of Execution In 2025
TruBridge's analyst price target has been revised downward from $24.75 to $22.60. Analysts cite recent coverage reflecting cautious optimism about the company's strategic shift toward revenue cycle management, while awaiting clearer evidence of execution before turning more positive.Article d’analyse • Nov 14
Solid Earnings Reflect TruBridge's (NASDAQ:TBRG) Strength As A Business
Even though TruBridge, Inc.'s ( NASDAQ:TBRG ) recent earnings release was robust, the market didn't seem to notice. We...Mise à jour du récit • Aug 15
AI And India Hub Will Boost Future Healthcare Efficiency
Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75. What's in the News TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.Nouveau récit • May 31
Digital Automation And AI Will Drive Healthcare Transformation
Increased AI-driven automation, expanded SaaS offerings, and digital transformation are expected to boost operational efficiency, recurring revenue growth, and earnings quality.Article d’analyse • Feb 14
Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Jan 17
TruBridge, Inc. (NASDAQ:TBRG) Shares Fly 27% But Investors Aren't Buying For Growth
TruBridge, Inc. ( NASDAQ:TBRG ) shares have continued their recent momentum with a 27% gain in the last month alone...Article d’analyse • Nov 13
TruBridge, Inc.'s (NASDAQ:TBRG) Business And Shares Still Trailing The Industry
TruBridge, Inc.'s ( NASDAQ:TBRG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right now...Article d’analyse • Aug 05
Is TruBridge (NASDAQ:TBRG) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • May 25
Is TruBridge, Inc. (NASDAQ:TBRG) Trading At A 38% Discount?
Key Insights The projected fair value for TruBridge is US$16.15 based on 2 Stage Free Cash Flow to Equity Current share...Article d’analyse • Feb 23
Computer Programs and Systems (NASDAQ:CPSI) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Article d’analyse • Sep 06
What Does Computer Programs and Systems, Inc.'s (NASDAQ:CPSI) Share Price Indicate?
Computer Programs and Systems, Inc. ( NASDAQ:CPSI ), is not the largest company out there, but it received a lot of...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 407 | 16 | N/A | N/A | 1 |
| 12/31/2027 | 371 | 16 | 36 | 63 | 5 |
| 12/31/2026 | 351 | 26 | 30 | 57 | 2 |
| 3/31/2026 | 346 | 4 | 30 | 47 | N/A |
| 12/31/2025 | 347 | 4 | 20 | 37 | N/A |
| 9/30/2025 | 347 | 3 | 21 | 37 | N/A |
| 6/30/2025 | 345 | -11 | 16 | 34 | N/A |
| 3/31/2025 | 345 | -18 | 22 | 39 | N/A |
| 12/31/2024 | 342 | -20 | 13 | 31 | N/A |
| 9/30/2024 | 337 | -59 | -10 | 10 | N/A |
| 6/30/2024 | 335 | -54 | -18 | 3 | N/A |
| 3/31/2024 | 334 | -52 | -33 | -10 | N/A |
| 12/31/2023 | 337 | -47 | -22 | -1 | N/A |
| 9/30/2023 | 337 | -1 | -7 | 15 | N/A |
| 6/30/2023 | 337 | 5 | 1 | 23 | N/A |
| 3/31/2023 | 335 | 11 | 9 | 30 | N/A |
| 12/31/2022 | 327 | 16 | 13 | 32 | N/A |
| 9/30/2022 | 317 | 18 | 26 | 43 | N/A |
| 6/30/2022 | 305 | 19 | 19 | 34 | N/A |
| 3/31/2022 | 290 | 22 | 33 | 46 | N/A |
| 12/31/2021 | 281 | 18 | 37 | 48 | N/A |
| 9/30/2021 | 273 | 16 | 42 | 51 | N/A |
| 6/30/2021 | 272 | 18 | 51 | 57 | N/A |
| 3/31/2021 | 263 | 14 | 50 | 55 | N/A |
| 12/31/2020 | 264 | 14 | 42 | 49 | N/A |
| 9/30/2020 | 268 | 22 | 45 | 51 | N/A |
| 6/30/2020 | 269 | 20 | 46 | 51 | N/A |
| 3/31/2020 | 275 | 20 | 39 | 43 | N/A |
| 12/31/2019 | 275 | 20 | N/A | 44 | N/A |
| 9/30/2019 | 276 | 16 | N/A | 35 | N/A |
| 6/30/2019 | 277 | 18 | N/A | 34 | N/A |
| 3/31/2019 | 279 | 17 | N/A | 29 | N/A |
| 12/31/2018 | 280 | 17 | N/A | 24 | N/A |
| 9/30/2018 | 286 | -11 | N/A | 20 | N/A |
| 6/30/2018 | 284 | -15 | N/A | 16 | N/A |
| 3/31/2018 | 284 | -13 | N/A | 17 | N/A |
| 12/31/2017 | 277 | -17 | N/A | 24 | N/A |
| 9/30/2017 | 263 | 6 | N/A | 23 | N/A |
| 6/30/2017 | 261 | 5 | N/A | 26 | N/A |
| 3/31/2017 | 262 | 6 | N/A | 11 | N/A |
| 12/31/2016 | 267 | 4 | N/A | 2 | N/A |
| 9/30/2016 | 247 | 5 | N/A | 2 | N/A |
| 6/30/2016 | 227 | 7 | N/A | 5 | N/A |
| 3/31/2016 | 206 | 11 | N/A | 18 | N/A |
| 12/31/2015 | 182 | 18 | N/A | 31 | N/A |
| 9/30/2015 | 184 | 21 | N/A | 39 | N/A |
| 6/30/2015 | 193 | 27 | N/A | 42 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de TBRG ( 25% par an) est supérieure au taux d'épargne ( 3.5% ).
Bénéfices vs marché: Les bénéfices de TBRG ( 25% par an) devraient croître plus rapidement que le marché US ( 16.8% par an).
Croissance élevée des bénéfices: Les bénéfices de TBRG devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de TBRG ( 4.8% par an) devrait croître plus lentement que le marché de US ( 11.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de TBRG ( 4.8% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de TBRG devrait être faible dans 3 ans ( 5.3 %).
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/22 04:55 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
TruBridge, Inc. est couverte par 23 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Matthew Gillmor | Baird |
| Stephanie Davis | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |